Speaker illustration

Miss Shari Pepplinkhuizen

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))

Equal performance of the subcutaneous and transvenous implantable cardioverter defibrillator across all age groups in the PRAETORIAN trial

Event: ESC Congress 2024

Topic: Device Treatment

Session: Subcutaneous and extravascular defibrillators: already mainstream?

Thumbnail

Antithrombotic therapy and the risk of pocket hematoma after subcutaneous implantable cardioverter-defibrillator implantation

Event: ESC Congress 2024

Topic: Device Treatment

Session: Subcutaneous and extravascular defibrillators: already mainstream?

Thumbnail

Clinical relevance of the single-lead ECG of the Apple Watch

Event: ESC Congress 2022

Topic: Remote Patient Monitoring and Telehealth

Session: e-Cardiology/Digital health - Remote monitoring 1

Thumbnail

Mechanism, follow-up and recurrence of inappropriate therapy in the PRAETORIAN trial: action reduces recurrence

Event: EHRA 2022

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: ePosters Day 2

Thumbnail

Exercise-optimised programming after S-ICD implantation contributes to a lower risk of inappropriate shocks in the latest generation of S-ICDs

Event: EHRA 2021

Topic: Genetic Aspects of Arrhythmias

Session: Scientific reports

Thumbnail

Exercise-optimized programming after S-ICD implantation contributes to a lower risk of inappropriate shocks in the latest generation S-ICDs

Event: EHRA 2021

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: Oral abstract session - Devices

Thumbnail